Publication number: 20240238367
Abstract: The present disclosure provides a method of treating hypercholesterolemia and other conditions related to PCSK9 activity, e.g. atherosclerosis, atherosclerotic cardiovascular disease, coronary heart disease, metabolic syndrome, acute coronary syndrome, or related cardiovascular disease and cardiometabolic conditions, by orally administering to the subject an amount of a compound of formula (I) wherein A? is selected from a pharmaceutically acceptable anion, and wherein the amount administered is from about 5 mg to about 300 mg of the compound of formula (I). The present invention is also directed to pharmaceutical compositions comprising a compound of formula (I), including particular salts of a compound of formula (I), and a permeation enhancer.
Type:
Application
Filed:
August 18, 2022
Publication date:
July 18, 2024
Inventors:
Douglas G. JOHNS, Puja BANKA, Zexun ZHOU, Artis KLAPARA, Fuh-rong TSAY, Jongrock KONG, Richard J. VARSOLONA, Richard DESMOND, Peter E. MALIGRES, Melanie MAROTA, Candice ALLEYNE, Grace A. OKOH, James C. DINUNZIO, Rebecca NOFSINGER, Li LI, Daniel J. SMITH, Majid MAHJOUR, Kenneth Alan KOEPLINGER, Yusheng XIONG, Peter W. WUEFLING, John D. HIGGINS